News Archives - Page 439 of 1256

ThursdayOct 14, 2021 2:11 pm

NetworkNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Featured in Audio Broadcast Discussing Real-World Data and Healthcare

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF), a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward, is at the center of the discussion of healthcare and real-world data in a recent NetworkNewsAudio release. The broadcast, titled “Real-World Data, Point-of-Care Testing Reshaping Healthcare, Detecting Diseases Sooner,” notes that insurers, healthcare providers, life sciences companies and governments alike face challenges such as rising costs and inconsistent outcomes. Evidence points toward real-world data, which is more accurate and cost efficient, making a positive impact on these challenges. The audio broadcast also mentioned that younger generations of patients are…

ThursdayOct 14, 2021 1:39 pm

NetworkNewsBreaks – Net Element Inc. (NASDAQ: NETE), Mullen Announce Crossover EV Nominated for Top LA Auto Show ZEVA Award

Net Element (NASDAQ: NETE), a global technology and value-added solutions group that supports electronic payments acceptance in a multichannel environment including point-of-sale (“POS”), e-commerce and mobile devices, and Mullen Automotive Inc. have announced that the Mullen FIVE electric vehicle (“EV”) crossover has been nominated for the ZEVA People’s Choice Top EV Crossover. Mullen is an emerging EV manufacturer, and the two companies are in the process of a stock-for-stock reverse merger agreement. The ZEVA award winners will be announced at the prestigious Los Angeles International Auto Show (“LAIAS”), which will be held Nov. 19–28, 2021. Public voting is open through Oct. 20, 2021.…

ThursdayOct 14, 2021 1:16 pm

NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Completion of BayMedica Acquisition

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing and clinical development of rare cannabinoids, has finalized the acquisition of BayMedica Inc., a private company based in the U.S. specializing in the manufacturing and commercialization of rare cannabinoids for the health and wellness sector. INM had announced the acquisition earlier. According to the announcement, the acquisition provides capabilities and resources to accelerate InMed’s commercial initiatives, including the development and unveiling of several new cannabinoids products in the consumer health and wellness sector. The combined technologies include synthetic biology, chemical synthesis and IntegraSyn(TM), a patented enzymatic biotransformation. The company noted that, with…

ThursdayOct 14, 2021 12:47 pm

NetworkNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Included in AdvisorShares Psychedelics ETF

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs, has announced its inclusion in the AdvisorShares Psychedelics ETF (the “Fund”), currently trading under ticker symbol PSIL on the NYSE Arca exchange. According to the update, the Fund, launched in September 2021, is actively trading and focuses on companies that devote a majority of assets to psychedelic drug development. The Fund has built a portfolio including over 25 psychedelic companies. PSIL represents an exciting milestone for Tryp with the potential to bring a more diverse shareholder base and to broaden life science exposure for…

ThursdayOct 14, 2021 11:12 am

NetworkNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) Enters Agreement to Bring Averi’s Cannabis-Infused Concepts to Life

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an emerging leader in innovative health and wellness beverages and products, has announced its entry into an agreement to manufacture and distribute white-label cannabis beverages for Averi Health Products. A new adult alternative beverage company founded by Terry Donnelly, creator and former CEO of the award-winning Hill Street Beverage Co., Averi will launch a portfolio of cannabis-infused beverages into the Canadian market. Under the agreement, Averi will leverage BevCanna’s extensive experience in producing beverages at scale as well as its sales license partnership for distribution to Canadian provincial buying groups. “Averi is…

ThursdayOct 14, 2021 9:58 am

NetworkNewsBreaks – Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Announces Collaboration to Provide Veterans with Free Ketamine Treatments

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), the leading psychedelic wellness platform, today announced two new partnerships between Ketamine Wellness Centers LLC (“KWC”) and the Veterans Administration (“VA”) Community Care Networks of Illinois and Minnesota . According to the update, the nation’s largest chain of psychedelic wellness clinics, KWC, will offer ketamine treatments to veterans at no out-of-pocket cost at their locations in Naperville, Illinois, and Burnsville, Minnesota. The program is designed to cover patients experiencing post-traumatic stress disorder (“PTSD”), major depression and chronic pain who have exhausted all traditional medical treatments. “This partnership between KWC and the VA…

WednesdayOct 13, 2021 2:20 pm

NetworkNewsBreaks – Orion Group Holdings, Inc. (NYSE: ORN) Featured in Research Note from Sidoti

Price Target Lowered; Estimates Lowered Orion Group Holdings (NYSE: ORN) was featured in a company-sponsored research note published by Sidoti & Company, LLC. The headline of the note reads, “View CFO Departure As Not Related To Company Fundamentals; We Lower Estimates On Expected Lower Utilization Rates In The Coming Quarters; Lower Target To $7 (From $8).” Click here to access the full report. About Orion Group Holdings, Inc. Orion Group Holdings, Inc., a leading specialty construction company serving the infrastructure, industrial and building sectors, provides services both on and off the water in the continental United States, Alaska, Canada and the…

WednesdayOct 13, 2021 2:11 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Impressive Findings of Oral THC Absorption Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that its recent oral tetrahydrocannabinol (“THC”) absorption study THC-A21-1 revealed that DehydraTECH(TM)-THC delivered via oral ingestion required only 15 minutes to deliver THC levels in blood plasma comparable to levels achieved at 45 minutes with concentration-matched controls. According to the update, DehydraTECH-THC delivered more THC into the bloodstream during the study than the industry standard medium chain triglyceride (“MCT” or “coconut oil”) based control formulation from the two-minute mark onwards, then dropped rapidly to the same level as the MCT control by the six-hour mark. “The…

WednesdayOct 13, 2021 1:58 pm

NetworkNewsBreaks – GP Strategies Corporation (NYSE: GPX) Completes Sale of EtaPRO(R) Business

Toshiba America Energy Systems Corporation (“TAES”), an affiliate of Toshiba Energy Systems & Solutions Corporation (“Toshiba ESS”), completed its acquisition of the EtaPRO(R) business from GP Strategies Corporation (NYSE: GPX), a global provider of workforce transformation solutions. The acquisition was originally announced in May 2021. Toshiba ESS is a long-time partner of GP Strategies and deploys EtaPRO technology to many of its power generation customers. The acquisition will enhance Toshiba's current global servicing and maintenance solutions for turbines and equipment across multiple platforms. According to the update, TAES will integrate EtaPRO employees into its operations and will continue operating existing…

WednesdayOct 13, 2021 1:54 pm

NetworkNewsBreaks – Clearmind Medicine Inc. (CSE: CMND) (FSE: CWY0) Announces Provisional Patent Application Related to Drug-Assisted Psychotherapy Methods

Clearmind Medicine (CSE: CMND) (FSE: CWY0), a psychedelic medicine biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and undertreated health problems, has filed a provisional patent application (“PPA”) with the United States Patent and Trademark Office (“USPTO”). The patent, which was filed on Oct. 8, 2021, covers CMND’s proprietary, novel methods of drug-assisted psychotherapy. According to the company, drug-assisted psychotherapy combines drug and psychological treatments designed to create a superior outcome when used together, including an improved patient-therapist relationship and increased flexibility in the patient’s mind, which allows a patient to explore new…

Financial news and publishing for public and private companies

Contact us: 212.418.1217

Breaks Categories: News